Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
Status:
Completed
Trial end date:
2020-11-05
Target enrollment:
Participant gender:
Summary
This study will follow participants who completed the TED-C14-006 study. The purpose of this
study is to evaluate the long-term safety and efficacy of teduglutide in pediatric
participants with Short Bowel Syndrome (SBS). This study will also offer teduglutide
treatment to eligible participants, regardless of treatment received in TED-C14-006 or
SHP633-301.